CC
NUS icon

Centiva Capital’s Nu Skin NUS Stock Holding History

Centiva Capital’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-43,891
Closed -$302K – 1965
2024
Q4 		$302K Sell
43,891
-25,092
-36% -$173K 0.01% 1136
2024
Q3 		$508K Buy
+68,983
New +$645K 0.01% 1239
2024
Q1 		– Sell
-13,003
Closed -$253K – 2089
2023
Q4 		$253K Buy
+13,003
New +$240K 0.01% 1300

Other funds holding NUS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Centiva Capital's NUS Position: Q1 2025 in Review

Centiva Capital sold out of Nu Skin (NUS) in Q1 2025, closing a stake of 43,891 shares — an estimated $302K sold.

Centiva Capital first reported a position in NUS in Q4 2023 and held it in 3 quarters. The position peaked at $508K in Q3 2024. 195 funds tracked by Wall St. Rank hold NUS as of Q1 2025.

  • Centiva Capital reported no remaining Nu Skin position as of Q1 2025 after selling out during the quarter.
  • Centiva Capital sold 43,891 Nu Skin shares in Q1 2025, an estimated $302K.
  • Centiva Capital first reported a position in Nu Skin in Q4 2023 and held it in 3 quarters.
  • Centiva Capital's Nu Skin position peaked at $508K in Q3 2024.
  • 195 funds tracked by Wall St. Rank held Nu Skin as of Q1 2025.

Based on Centiva Capital's 13F filing for Q1 2025, filed 15 May 2025.